Microfine zinc oxide (Z-Cote) as a photostable UVA/UVB sunblock agent


      Background: Microfine zinc oxide (Z-Cote) is used as a transparent broad-spectrum sunblock to attenuate UV radiation (UVR), including UVA I (340-400 nm). Objective: Our purpose was to assess the suitability of microfine zinc oxide as a broad-spectrum photoprotective agent by examining those properties generally considered important in sunscreens: attenuation spectrum, sun protection factor (SPF) contribution, photostability, and photoreactivity. Methods: Attenuation spectrum was assessed by means of standard spectrophotometric methods. SPF contribution was evaluated according to Food and Drug Administration standards. Photostability was measured in vitro by assessing SPF before and after various doses of UVR. Photoreactivity was evaluated by subjecting a microfine zinc oxide/organic sunscreen formulation to escalating doses of UVR and determining the percentage of organic sunscreen remaining. Results: Microfine zinc oxide attenuates throughout the UVR spectrum, including UVA I. It is photostable and does not react with organic sunscreens under irradiation. Conclusion: Microfine zinc oxide is an effective and safe sunblock that provides broad-spectrum UV protection, including protection from long-wavelength UVA. (J Am Acad Dermatol 1999;40:85-90.)
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Tyrrell RM.
        Oxidant, antioxidant status and photocarcinogenesis: the role of gene activation.
        Photochem Photobiol. 1996; 63: 380-386
        • Black HS
        • deGruijl FR
        • Forbes PD
        • Cleaver JE.
        Photocarcinogenesis: an overview.
        Photochem Photobiol. 1997; 40: 29-47
        • Drobetsky EA
        • Turcotte J
        • Chateauneuf A.
        A role for ultraviolet A in solar mutagenesis.
        Proc Natl Acad Sci U S A. 1995; 92: 2350-2354
        • Kielbassa C
        • Roza L
        • Epe B.
        Wavelength dependence of oxidative DNA damage induced by UV and visible light.
        Carcinogenesis. 1997; 18: 811-816
        • Stary A
        • Robert C
        • Sarasin A.
        Deleterious effects of ultraviolet A radiation in human cells.
        Mutat Res. 1997; 383: 1-8
        • de Laat JM
        • de Gruijl FR.
        The role of UVA in the aetiology of non-melanoma skin cancer.
        Cancer Surv. 1996; 26: 173-191
        • LeVee GJ
        • Oberhelman L
        • Anderson T
        • Koren H
        • Cooper KD.
        UVA II exposure of human skin results in decreased immunization capacity, increased induction of tolerance and a unique pattern of epidermal antigen-presenting cell alteration.
        Photochem Photobiol. 1997; 65: 622-629
        • Streilein JW
        • Taylor JR
        • Vincek V
        • Kurimoto I
        • Shimizu T
        • Tie C
        • et al.
        Immune surveillance and sunlight-induced skin cancer.
        Immunol Today. 1994; 15: 174-179
        • Setlow RB
        • Woodhead AD.
        Temporal changes in the incidence of malignant melanoma: explanation from action spectra.
        Mutat Res. 1994; 307: 365-374
        • Husain Z
        • Pathak MA
        • Flotte T
        • Wick MM.
        Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethylbenz(?)anthracene application and ultraviolet irradiation.
        Can Res. 1991; 49: 64-70
        • Westerdahl J
        • Olsson H
        • Masback A
        • Ingvar C
        • Jonsson N
        • Brandt L
        • et al.
        Use of sunbeds or sunlamps and malignant melanoma in southern Sweden.
        Am J Epidemiol. 1994; 140: 691-699
        • Walter SD
        • Marrett LD
        • From L
        • Hertzman C
        • Shannon HS
        • Roy P.
        The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps.
        Am J Epidemiol. 1990; 131: 232-243
        • Cascinelli N
        • Krutmann J
        • MacKie R
        • Pierotti M
        • Prota G
        • Rosso S
        • et al.
        European School of Oncology advisory report: sun exposure, UVA lamps and risk of skin cancer.
        Eur J Cancer. 1994; 30A: 548-560
        • Stern RS
        • Nichols KT
        • Vakeva LH.
        Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA): The PUVA Follow-Up Study.
        N Engl J Med. 1997; 336 ([see comments]): 1041-1045
        • Lavker RM
        • Gerberick GF
        • Veres D
        • Irwin CJ
        • Kaidbey KH.
        Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin.
        J Am Acad Dermatol. 1995; 32: 53-62
        • Lavker RM
        • Veres DA
        • Irwin CJ
        • Kaidbey KH.
        Quantitative assessment of cumulative damage from repetitive exposures to suberythemogenic doses of UVA in human skin.
        Photochem Photobiol. 1995; 62: 348-352
        • Scharffetter K
        • Wlaschek M
        • Hogg A
        • Bolsen K
        • Schothorst A
        • Goerz G
        • et al.
        UVA irraiation induces collagenase in human dermal fibroblasts in vitro and in vivo.
        Arch Dermatol Res. 1991; 283: 506-511
        • Mitchell K
        • Mitchnick M.
        Visibly transparent UV sunblock agents and methods of making same.
        (US Patent No. 5,587,148)1996
        • Fairhurst D
        • Mitchnik MA.
        Particulate sun blocks: general principles.
        in: Sunscreens, development, evaluation, and regulatory aspects. Marcel Dekker, New York1997: 313-352
        • Diffey BL.
        A method for broad spectrum classification of sunscreens.
        Intl J Cosmet Sci. 1994; 60: 47-52
      1. Sunscreen drug products for over-the-counter human use; tentative final monographs: proposed rule, the code of federal regulations. Food and Drug Administration, Washington (DC)1998: 28-33 (21CFR Part 352)
        • Bickley RI
        • Hogg LT
        • Bonzales-Carreno T
        • Palmisano L.
        A comparative study of the photocatalytic activities of iron-titanium (IV) oxide photocatalyst prepared by various methods: spray pyrolysis, impregnation, and co-precipitation.
        in: Preparation of catalysts. BV Elsevier Science, Amsterdam1995: 589-596
        • Anderson MW
        • Hewitt JP
        • Spruce SR.
        Broad-spectrum physical sunscreens: titanium dixoide and zinc oxide.
        in: Sunscreens, development, evaluation, and regulatory aspects. Marcel Dekker, New York1997: 353-397
        • Brown HE.
        Optical properties..
        in: Zinc oxide: properties and applications. International Lead Zinc Research Organization, New York1976: 10-12
        • Deflandre A
        • Lang G.
        Photostability assessment of sunscreens: benzylidene camphor and dibenzoylmethane derivatives.
        Intl J Cosmet Sci. 1988; 10: 53-62
        • Lowe NJ
        • Friedlander J.
        Prevention of photodamage with sun protection and sunscreens.
        in: Photodamage. Blackwell Science, Cambridge1995: 201-220
        • Kochevar IE.
        Molecular and cell effects of UV radiation relevant to chronic photodamage.
        in: Photodamage. Blackwell Scientific, Cambridge1995: 51-67
        • Sayre RM
        • Dowdy JC.
        Avobenzone and the photostability of sunscreen products.
        Photodermatol Photoimmunol Photomed. 1998; 38
        • Wamer WG
        • Yin JJ
        • Wei RR.
        Oxidative damage to nucleic acids photosensitized by titanium dioxide.
        Free Radic Biol Med. 1997; 23: 851-858
        • Dunford R
        • Salinaro A
        • Cai L
        • Serpone N
        • Horkoshi S
        • Hidaka H
        • et al.
        Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients.
        FEBS. 1997; 418: 87-90
        • Hidaka H
        • Horikoshia S
        • Serpone N
        • Knowland J.
        In vitro photochemical damage to DNA, RNA and their bases by an inorganic sunscreen agent on exposure to UVA and UVB radiation.
        Photochem Photobiol. 1997; 111: 205-213
        • Dussert AS
        • Gooris E
        • Hemmerle J.
        Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum.
        Int J Cosmet Sci. 1997; 19: 119-129
        • Gasparro FP
        • Mitchnick M
        • Nash JF.
        A review of sunscreen safety and efficacy.
        Photochem Photobiol. 1998; 68: 243-256
        • Derry JE
        • McLean WM
        • Freeman JB.
        A study of the percutaneous absorption from topically applied zinc oxide ointment.
        J Parenteral Enteral Nutr. 1983; 7: 131-135
        • Berg JM
        • Shi Y.
        The galvanization of biology: a growing appreciation for the roles of zinc.
        Science. 1996; 271: 1081-1085